Specifically, we found that CyPA (i) is secreted from VSMC obtained by MFS patients’ TAA samples after treatment with AngII and (ii) orchestrates the activation of deleterious pathways leading to fibrosis in MFS through the upregulation and activation of EMMPRIN. The gene discussed is BSG; the disease is Marfan syndrome.